Myeloma 2016: Panel discussion on gene modified T-cells
Edward Stadtmauer et al.
Improving the outcomes of transplantation with bispecific antibodies
Defibrotide: Redefining the treatment for severe veno-occlusive disease (sVOD)
ENDEAVOUR, ASPIRE and TOURMALINE-MM1 trial results for multiple myeloma
How next-generation sequencing will change the treatment of multiple myeloma